Graves’ disease is diagnosed through a combination of blood tests, antibody testing, and sometimes imaging. The process typically starts with a simple blood draw that measures thyroid hormone levels, then narrows down the cause with more specific tests. Most people get a clear answer within a few days to a couple of weeks, depending on which tests their doctor orders.
Graves’ disease is one of the most common causes of an overactive thyroid, affecting roughly 20 to 50 people per 100,000 each year. Because several different conditions can make the thyroid overactive, diagnosis isn’t just about confirming hyperthyroidism. It’s about proving Graves’ disease is the specific cause.
The First Step: Thyroid Blood Tests
The diagnostic process almost always begins with a thyroid panel, a standard blood test that measures TSH (thyroid-stimulating hormone) along with free T4 and free T3, the two hormones your thyroid produces. In Graves’ disease, the pattern is distinctive: TSH drops to very low or undetectable levels while free T4, free T3, or both are elevated. TSH is low because the brain senses too much thyroid hormone in the blood and stops sending the signal to make more.
Sometimes blood work reveals what’s called subclinical hyperthyroidism, where TSH is suppressed but T4 and T3 are still in the normal range. This can represent an early or mild stage of the disease. Another useful clue from blood work is the ratio of T3 to T4. A T3/T4 ratio greater than 20 (in standard units) suggests Graves’ disease specifically, because the Graves’ thyroid tends to produce a disproportionate amount of T3. This ratio can help distinguish Graves’ from other causes of thyrotoxicosis, like thyroid inflammation, where the pattern is different.
Antibody Tests Confirm the Cause
Abnormal thyroid levels tell your doctor the thyroid is overactive, but not why. That’s where antibody testing comes in. Graves’ disease is an autoimmune condition, meaning the immune system produces antibodies that latch onto the TSH receptor on thyroid cells and force them to overproduce hormones. Detecting these antibodies in your blood is the most direct way to confirm a Graves’ diagnosis.
Two types of antibody tests are commonly used. The first, called TRAb (TSH receptor antibodies), is the standard method for confirming diagnosis, monitoring treatment, and predicting whether the disease will relapse after treatment ends. TRAb testing detects all antibodies that bind to the TSH receptor, including stimulating, blocking, and neutral types. The second, called TSI (thyroid-stimulating immunoglobulins), is a newer test that specifically targets the stimulating antibodies responsible for driving hormone overproduction. TSI testing has a sensitivity of 96% and specificity of 99% for Graves’ disease, meaning it catches nearly every true case and almost never gives a false positive.
In practice, one or both of these tests will be ordered depending on your doctor’s preference and what’s available at the lab. A positive result, combined with the blood work pattern described above, is usually enough to confirm Graves’ disease without further testing.
When Imaging Is Needed
If antibody results are borderline or unavailable, or if your doctor needs to rule out other causes of hyperthyroidism, imaging studies can fill in the picture.
A radioactive iodine uptake test (RAIU) is the most definitive imaging tool. You swallow a small amount of radioactive iodine, and a scan measures how much your thyroid absorbs over 24 hours. In Graves’ disease, the entire thyroid is overactive, so it takes up iodine uniformly and at an elevated rate, often above 50%. This pattern looks very different from a toxic nodular goiter, where only one or a few spots light up, or from thyroiditis (thyroid inflammation), where uptake is actually very low because the gland is leaking stored hormone rather than making new hormone.
Thyroid ultrasound with Doppler imaging is another option, particularly useful when radioactive iodine testing isn’t appropriate (such as during pregnancy or breastfeeding). In Graves’ disease, ultrasound typically shows an enlarged thyroid with increased blood flow throughout the gland, sometimes called “thyroid inferno” because of the dramatic color pattern on Doppler. The gland also tends to appear darker than normal (hypoechoic). While ultrasound is less definitive than RAIU for distinguishing Graves’ from other causes, it’s safe, quick, and widely available.
The Physical Exam Still Matters
Before any tests are ordered, a physical exam often raises the initial suspicion. Your doctor will feel your neck for an enlarged thyroid (goiter), check your heart rate, look at your hands for tremor, and examine your eyes. Graves’ disease is unique among thyroid conditions in that it can affect the eyes, causing them to bulge, become red, or feel gritty and painful. About 25 to 50% of people with Graves’ develop some degree of eye involvement.
When eye disease is present, doctors assess its severity using a scoring system that evaluates seven specific signs: spontaneous pain behind the eyes, pain with eye movement, redness of the eyelids, redness of the whites of the eyes, swelling of the eye’s surface membranes, swelling of the small fleshy bump in the inner corner of the eye, and puffiness or fullness of the eyelids. Each sign gets one point, and a score above 3 (out of 7) indicates active eye disease that may need its own treatment. The presence of these eye changes in someone with hyperthyroidism is often enough to diagnose Graves’ on its own, even without antibody testing.
Distinguishing Graves’ From Similar Conditions
Several conditions can cause hyperthyroidism, and getting the right diagnosis matters because treatments differ. Toxic multinodular goiter, where enlarged thyroid nodules independently produce excess hormone, is the most common condition confused with Graves’. Antibody testing is the most reliable way to tell them apart: TRAb or TSI will be positive in Graves’ and typically negative in toxic nodular goiter, though up to 50% of patients with one type of multinodular goiter can have detectable TSH receptor antibodies, which complicates the picture. In those ambiguous cases, the radioactive iodine uptake pattern (diffuse in Graves’, patchy in nodular goiter) usually settles the question.
Thyroiditis, or inflammation of the thyroid, is the other major mimic. It causes a temporary surge of thyroid hormone as the inflamed gland dumps its stored supply into the bloodstream. The key difference is that thyroiditis is self-limiting and doesn’t involve ongoing hormone overproduction. On a radioactive iodine uptake test, thyroiditis shows very low uptake (the gland isn’t actively making hormone), while Graves’ shows high uptake. The T3/T4 ratio also helps here, since it tends to be lower in thyroiditis than in Graves’.
Biotin Supplements Can Skew Results
If you take biotin supplements, this is important to know before getting tested. Biotin, commonly found in hair, skin, and nail supplements, interferes with the type of immunoassay used to measure thyroid hormones and TSH receptor antibodies. It can make TSH appear falsely low and free T4 and T3 appear falsely high, mimicking the exact pattern of Graves’ disease. In documented cases, biotin doses as low as 10 mg per day have caused significant interference, and higher doses (100 mg three times daily, sometimes prescribed for neurological conditions) have produced lab results indistinguishable from Graves’ disease, including a false-positive TRAb result.
The interference can persist for at least 16 hours after the last dose. If you’re taking any supplement containing biotin, stop it at least two to three days before thyroid blood work to avoid misleading results. Many multivitamins contain small amounts of biotin as well, so check labels or mention all supplements to your doctor before testing.